Plimoth Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.19M | Sell |
49,223
-855
| -2% | -$22.4K | 0.24% | 86 |
|
|
2026
Q1 | $1.41M | Buy |
50,078
+323
| +0.6% | +$8.6K | 0.31% | 76 |
|
|
2025
Q4 | $1.24M | Sell |
49,755
-610
| -1% | -$15.4K | 0.28% | 80 |
|
|
2025
Q3 | $1.28M | Sell |
50,365
-1,670
| -3% | -$41.2K | 0.29% | 80 |
|
|
2025
Q2 | $1.26M | Sell |
52,035
-240
| -0.5% | -$5.6K | 0.3% | 80 |
|
|
2025
Q1 | $1.32M | Sell |
52,275
-4,470
| -8% | -$117K | 0.35% | 76 |
|
|
2024
Q4 | $1.51M | Sell |
56,745
-4,765
| -8% | -$129K | 0.39% | 69 |
|
|
2024
Q3 | $1.78M | Sell |
61,510
-2,555
| -4% | -$74.5K | 0.45% | 68 |
|
|
2024
Q2 | $1.79M | Sell |
64,065
-658
| -1% | -$18.1K | 0.48% | 61 |
|
|
2024
Q1 | $1.8M | Buy |
64,723
+1,406
| +2% | +$39K | 0.48% | 64 |
|
|
2023
Q4 | $1.82M | Sell |
63,317
-4,084
| -6% | -$123K | 0.53% | 60 |
|
|
2023
Q3 | $2.24M | Sell |
67,401
-1,275
| -2% | -$45.1K | 0.7% | 50 |
|
|
2023
Q2 | $2.52M | Buy |
68,676
+725
| +1% | +$28.2K | 0.75% | 45 |
|
|
2023
Q1 | $2.77M | Buy |
67,951
+2,145
| +3% | +$92.6K | 0.86% | 39 |
|
|
2022
Q4 | $3.37M | Sell |
65,806
-4,014
| -6% | -$192K | 1.09% | 25 |
|
|
2022
Q3 | $3.06M | Sell |
69,820
-650
| -0.9% | -$31.6K | 1.06% | 29 |
|
|
2022
Q2 | $3.69M | Sell |
70,470
-2,456
| -3% | -$125K | 1.17% | 23 |
|
|
2022
Q1 | $3.77M | Sell |
72,926
-859
| -1% | -$44.6K | 1% | 28 |
|
|
2021
Q4 | $4.36M | Sell |
73,785
-1,028
| -1% | -$50.9K | 1.1% | 23 |
|
|
2021
Q3 | $3.22M | Sell |
74,813
-1,115
| -1% | -$49.4K | 0.91% | 33 |
|
|
2021
Q2 | $2.97M | Sell |
75,928
-2,726
| -3% | -$106K | 0.83% | 37 |
|
|
2021
Q1 | $2.85M | Sell |
78,654
-21,475
| -21% | -$762K | 0.84% | 42 |
|
|
2020
Q4 | $3.69M | Sell |
100,129
-10,675
| -10% | -$392K | 1.15% | 25 |
|
|
2020
Q3 | $3.86M | Buy |
110,804
+625
| +0.6% | +$21.9K | 1.29% | 19 |
|
|
2020
Q2 | $3.42M | Sell |
110,179
-5,869
| -5% | -$199K | 1.22% | 19 |
|
|
2020
Q1 | $3.59M | Sell |
116,048
-3,009
| -3% | -$103K | 1.51% | 14 |
|
|
2019
Q4 | $4.43M | Sell |
119,057
-2,946
| -2% | -$105K | 1.43% | 14 |
|
|
2019
Q3 | $4.16M | Sell |
122,003
-3,320
| -3% | -$121K | 1.36% | 14 |
|
|
2019
Q2 | $5.15M | Sell |
125,323
-5,894
| -4% | -$234K | 1.69% | 11 |
|
|
2019
Q1 | $5.29M | Buy |
131,217
+7,958
| +6% | +$319K | 1.76% | 11 |
|
|
2018
Q4 | $5.11M | Sell |
123,259
-2,376
| -2% | -$98.6K | 1.88% | 10 |
|
|
2018
Q3 | $5.25M | Sell |
125,635
-1,902
| -1% | -$73.2K | 1.7% | 10 |
|
|
2018
Q2 | $4.39M | Sell |
127,537
-3,755
| -3% | -$128K | 1.5% | 14 |
|
|
2018
Q1 | $4.42M | Sell |
131,292
-654
| -0.5% | -$22.5K | 1.53% | 12 |
|
|
2017
Q4 | $4.53M | Buy |
+131,946
| New | +$4.5M | 1.62% | 14 |
|
Other funds holding PFE
Plimoth Trust's PFE Position: Q2 2026 in Review
Plimoth Trust reduced its Pfizer (PFE) stake by 1.7% in Q2 2026, selling an estimated $22.4K and leaving 49,223 shares worth $1.19M. The position accounts for 0.24% of the portfolio, ranked #86.
Plimoth Trust first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.29M in Q1 2019. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Plimoth Trust held 49,223 shares of Pfizer worth $1.19M as of Q2 2026.
- Plimoth Trust sold 855 Pfizer shares in Q2 2026, an estimated $22.4K.
- Pfizer made up 0.24% of Plimoth Trust's portfolio in Q2 2026, its #86 holding.
- Plimoth Trust first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Plimoth Trust's Pfizer position peaked at $5.29M in Q1 2019.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Plimoth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.